The Pentagon announced a new health initiative that will screen service members for testosterone deficiency as part of the annual health assessment.
The program requires mandatory testing for personnel over age 30 and offers optional screening for those under 30; individuals identified with low testosterone may be offered replacement therapy.
Department officials described the measure as a means to restore natural physiological capacity, emphasizing that it is intended to support health and combat readiness rather than provide performance enhancement.
The announcement quickly became a point of political contention, with several Democratic lawmakers characterizing the effort as comparable to gender‑affirming care.
Senators and representatives posted statements linking the testosterone program to gender‑affirming treatments, and one member raised the issue during a House hearing, describing the policy as “absurd.”
Critics suggested the screening could be extended to assess whether elected officials meet physiological standards for office.
Online commentary included strong rebuttals, with users asserting that testosterone replacement for men with a medical deficiency differs fundamentally from gender transition procedures.
Medical professionals noted that testosterone influences muscle mass, bone density, red blood cell production, metabolism, sexual function, mood, concentration, and overall physical performance, and that deficiency can lead to fatigue, weakness, and cognitive decline.
Veterans’ groups and health advocates welcomed the focus on endocrine health, citing longstanding calls for greater attention to hormonal issues within the armed forces.
Senior officials from the Department of Health and Human Services expressed support for the initiative, highlighting that optimal testosterone levels contribute to strength, endurance, body composition, cognitive function, and mission readiness.
